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ABSTRACT 
This paper presents localized and temporal control of release kinetics over 3-dimensional (3D) hybrid 
wound devices to improve wound healing process. Imaging study is performed to extract wound bed 
geometry in 3D. Non-Uniform Rational B-Splines (NURBS) based surface lofting is applied to generate 
functionally graded regions. Diffusion-based release kinetics model is developed to predict time-based 
release of loaded modifiers for functionally graded regions. Multi-chamber single nozzle solid freeform 
dispensing system is used to fabricate wound devices with controlled dispensing concentration. 
Spatiotemporal control of biological modifiers thus enables a way to achieve target delivery to improve 
wound healing.    
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1 INTRODUCTION 
Loss of skin integrity due to injuries or serious illness may bring disabilities or even death. Main causes 
of significant skin loss are thermal injuries with around 1 million yearly emergency room visits, traumas 
(35 million wounds/yr in the United States) and chronic ulcerations [1]. Approximately 2 million cases of 
chronic ulceration are diagnosed every year. Due to possible lack of synchrony in the order of healing 
process, a chronic wound may fail to heal.  
Despite extensive research, wound healing remains partially understood. Human skin serves as a 
protective barrier against the environment and is composed of two layers: keratinized stratified outer layer 
(epidermis) and collagen-rich inner layer (dermis) [2]. Serious injuries or illnesses damage the epidermis 
and sometimes even penetrates through the dermis. Wound contraction and matrix remodeling occur in 
the dermis in parallel with epidermal cell migration and proliferation during deep wound healing. In the 
literature, wound healing of mammalian skins has been analyzed both experimentally and theoretically [3-
7]. Several mathematical models have been proposed concentrating specifically upon the mechanism 
involved in epidermal healing. However, 3-D healing modeling of deep wounds and closure has not been 
investigated, and majority of research has been done by assuming a 1-D or 2-D healing process. Wound 
closure is indeed the centripetal movement process of the wound periphery and adjacent uninjured skin 
toward the wound center [8]. The healing of convex wound shapes follows a linear relationship between 
area and perimeter while the distance from the wound perimeter to any given point within the wound 
surface is always definable via a linear distance [4]. Moreover, several imaging techniques such as Laser 
Doppler Imaging [9], noninvestment tools with magnetic resonance imaging (MRI) [10]  and 3D active 
contour segmentation [11] are used to capture wound geometry during healing process, and predict 
wound healing based on geometry, area and appearance [12-15].      
Biomaterials have been extensively used in medical applications. Alginates have been widely applied 
as hydrogel synthetic extracellular matrices (ECMs) for cell immobilization, cell transplantation and 
tissue engineering due to their physical properties that are similar to natural tissues [16]. Due to their 
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gelatin property during in contact with body fluid, alginates have been one of the most popular 
biomaterials in wound care [17]. This property prevents the wound surface from drying out and provides 
a moist wound environment that leads a better repair of wound with less tissue loss from desiccation [18]. 
Besides, this eliminates fibre entrapment in the wound, which is a major cause of patient trauma during 
wound dressing removal [19]. Moreover, ionically crosslinked alginates release ions during in contact 
with body fluids that reduce bleeding during several surgical interventions [20]. Furthermore, alginate is 
highly absorbent (up to 15-20 times its own weight) and nonadherent that enables it to remain in wound 
bed for several days [21]. Several biological modifiers (i.e. growth factors and proteins) are used to 
enhance quantity and quality of regenerating skin tissue depending on their activity with target cells and 
the extracellular matrix environment [3]. A wealth of growth factors such as epidermal growth factors 
(EGF), platelet-derived growth factor (PDGF) and keratinocyte growth factor (KGF) regulate wound 
healing [4]. Release of these modifiers with spatial and temporal gradient concentration mediates tissue 
regeneration process [22]. It develops a mental biology, in which cells are guided by a mechanism with 
respect to obtained spatial and directional cues [23]. As a result, wound dressings in tissue engineering 
should be developed in way that they enable controlled release scheme of biological modifiers with 
distinct spatial gradient to guide specific cues to the cellular microenvironment. Wound healing can be 
enhanced by controlling localized protein and growth factor release. Adjusting the healing time of a 
specific region with respect to the release time of corresponding growth factors or proteins would have a 
great impact on wound healing [24]. Target delivery of biological modifiers at a specific site over the 
wound space can be enabled by synchronizing the delivery of controlled amount of biological modifiers 
with tissue regeneration.  
In the literature, tremendous efforts have been made to analyze the use of protein and growth factors 
for improving chronic or delayed skin wound closure [25, 26]. MacKay and Miller [27] studied effects of 
nutritional and botanical support on wound healing process and concluded that adequate protein intake is 
necessary for proper wound healing otherwise; depletion of protein delays wound healing and inhibits 
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wound remodeling. Choate and Khavari [28] showed that the bioactivity of proteins and growth factors is 
difficult to maintain in the wound space due to protein instability in protein-rich regions or resulting side 
effects when applied growth factor amount is high, and Putney and Burke [24] necessitated the spatial and 
temporary control of protein and growth factors in a wound device due to their short biological half-life, 
potential carcinogenesis risk and lack of tissue selectivity. Proteins can denature under a variety of 
circumstances such as changes in temperature, pH and hydrophobic environments [29].  
In this paper, cells, proteins, growth factors, drugs and surfactants, which can control cellular 
environment and tissue regeneration, and be delivered by means of microspheres, are named with a 
general term “biological modifiers”. Development of 3D engineered wound devices with superior control 
over cell-biological modifier interactions is still very much infancy. Advancing through heterogeneous 
multifold wound dressings with controlled release fashion enables synchronization of regenerating tissue 
with the release kinetics of loaded biological modifiers. This might be an engineering challenge and 
promising approach for improved and efficient tissue regeneration. The most critical limitations: the 
selection of proper biological modifier(s) incorporation, precise control over concentration gradient and 
timing should be overcome. Hence, wound devices need to be designed, modeled and fabricated in a way 
that biological modifiers should be incorporated and released in a specific spatial and temporal orientation 
to mimic the natural wound healing process. The goal of this paper is to develop a framework that enables 
design, modeling and fabrication of 3D hybrid wound devices for spatiotemporal control of biomaterial 
and loaded biological modifier composition.   
2 MATERIALS AND METHODS 
2.1 Materials 
Alcian blue, sodium alginate from brown algae and calcium chloride were purchased from Sigma-
Aldrich. Micro-glass beads in powder form were purchased from Corpuscular Inc. Nozzle tips for 
dispensing systems were purchased from EFD®.  
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2.2 Preparation and Fabrication of Alginate Wound Dressings  
Alginate solutions with 3.5% and 4.5% (w/v) concentrations were prepared by suspending sodium 
alginate (SA) into DI water. Micro-glass beads in 0.36% and 0.54% (w/v) concentration were mixed in 
3.5% and 4.5% (w/v) alginate solutions, respectively. Calcium chloride was suspended in DI water to 
obtain 0.6% (w/v) calcium chloride solution. Then SA/bead/DIwater solutions were stirred for 30min in 
room temperature to get even distribution. Biofabrication of wound devices is performed by using a 
multi-chamber single nozzle dispensing system. Fabrication process is biologically compatible. The 
system runs in room temperature under low pressure (0-5 psi) to reduce fluidic shear forces that can 
damage incorporated modifiers or diminish their active properties. The dispensing system is driven by a 
FlashCut CNC 3D motion controller. A PC is connected to the system to control the motion in 3D. 
Toolpath for the motion is realized through importing CAD models in stereolithography (STL) format 
followed by G-code generation using visual basic-based in-house developed script. The multi-chamber 
single nozzle assembly is mounted on the 3D motion control unit. The multi-chamber single nozzle 
assembly consists of multiple biomaterial chambers and a single converging nozzle unit, where two 
different biomaterials can be mixed statically and extruded with unique properties. The volume of the 
static mixture nozzle is optimized while nozzle volume determines the quality and the evenness of 
physical properties of the dispensed biomaterial. Biomaterial chambers are connected to a pressure 
control unit (Nordson EFD), where the air pressure assists in extruding the biomaterial through the 
dispensing unit. Material flow and concentration through the nozzle is controlled by regulating positive 
chamber pressures connected to the air pressure control unit. Mixing two different concentrations from 
each chamber enables dispensing varying concentration of alginate and loaded microspheres by time. 
Final solutions were deposited through 250 µm nozzle tip. The system allows extrusion of continuous 
customized filaments with variational biomaterial and biological modifier properties enabling controlled 
release kinetics. Calcium chloride solution is then dispensed onto printed alginate structure through 
another nozzle to provide crosslinking between the alginate anion and the calcium cation. Dark field 
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images of fabricated samples are taken by 5.0x1.0x1.0 optic lenses. The reader is referred to our earlier 
work [30] for further details of the dispensing system.  
2.3 Wound Bed Surface Construction 
Digital full thickness wound images are used to generate 3D wound bed geometry using Image J software 
3D plug-in.  Pixel values obtained from the digital image are converted into point cloud in CAD. Noise in 
point clouds is removed. 3D NURBS surface is then fitted to point cloud in Rhinoceros 4.0 software [31]. 
Constructed NURBS surface in this section is defined as the external surface of the developed wound 
device. 
2.4 Geometric Modeling: Functionally Graded Region Generation 
3D NURBS surface constructed in Section 2.3 is used to create functionally graded regions. The aim of 
this section is to discretize wound device geometry into a number of regions with various biomaterial and 
modifier concentration. Discretization of the device should follow how a wound heals on human skin. In 
order to mimic 3-D wound healing process to partition the wound device into uniform functional regions, 
concentration variation can be represented with relation to the 3D wound space boundaries. Mimicking 
natural healing process is desirable for the discretization procedure. In this study, we propose 3D lofting 
based wound healing process, in which a wound bed surface is morphed and converged into a final 
healing point. Based on our earlier work [32], final healing point can be approximated as the projection of 
deepest wound bed surface onto the top surface of the wound. Hence, parametric discretization is 
performed from wound bed surface to the final healing point. Release kinetics of modifiers can be 
temporarily controlled by controlling biomaterial and loaded modifier distribution spatially. Thus, 3D 
geometry of customized device is formed by partitioning the device geometry into uniform regions with 
uniform existence of biomaterials and modifiers. In this section, 3D lofting procedure is presented to 
mimic natural wound healing process. The wound bed surface So(u,v) of the wounded volume can be 
defines as a NURBS surface:  
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where jiP ,  are the control points of the wound surface and jiw ,  are the weights of each jiP , . )(, uN pi  and 
)(, vN qj  are the B-spline basis functions defined on the knot vectors, U and V, with degree p and q, 
respectively.  
 
Figure 1: Morphing process: (a) lofted surface generation and (b) construction of lofted volume. 
Figure 1(a) illustrates a morphing process, in which a NURBS surface (So(u,v)) morphs into a point Po. 
Morphing proceeds through morphing trajectory (T(s)), in which T(s) is defined as a linear 
correspondence between So(u,v) and Po [33]: 
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In Equation (2), mC  are the control points of the trajectory and mw  are the weights of each mC . )(, sN tm  
is the B-spline basis function defined on the knot vector S with degree t. By combining Equation (2) and 
(3), interpolation between So(u,v) and Po along the trajectory T(s) gives the functionally graded regions 
Rn, which defines the lofted volume as below:  
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where mjiP ,,  are the control points of the lofted volume and mjiw ,,  are the weights of each mjiP ,, .    
)(, uN pi , )(, vN qj  and )(, sN tm  are the B-spline basis functions defined on the knot vectors, U, V, S with 
degree p, q, t, respectively. Lofted volumes generated in Figure 2(b) stand as functionally graded regions, 
in which different biomaterial and biological modifier composition can be assigned.  
2.5 Construction of Hybrid Devices 
Solid freeform fabrication (SFF) has been widely used for constructing tissue engineered devices due to 
its high accuracy in micro-scale fabrication resolution [34, 35]. Applied SFF technology is recently 
utilized in drug metabolism studies and direct cell printing process for layer-by-layer dispensing of 3D 
alginate tissue scaffolds [36, 37]. In order to achieve truly interconnected internal architecture for cell 
growth and proliferation, the device is formed by depositing cylindrical micro-filaments parallel to each 
other in every layer using a certain lay-down pattern. In this research, a visual basic script was developed 
in Rhinoceros software to prepare fabrication process plan for hybrid device development. Firstly, lofted 
volumes are uniformly sliced where multiple contours are generated on each slice. The slice thickness is 
set to be equal to filament thickness. Next, corresponding filament properties including biomaterial and 
biomolecule concentrations are assigned to each region on each slice. Horizontal deposition over each 
slice is then started with generating a number of equidistance horizontal lines, where intersection of these 
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horizontal lines with the contours are defined as starting and ending points of filament deposition. Then, 
toolpath is generated through tracing each slice by adding straight filaments in lay-down pattern along 
equidistance lines with orientation direction 0°/90°. During straight filament deposition, composition of a 
filament changes when the filament enters a new functionally gradient region and new concentration 
values are assigned based on the concentration profile of each region, which is assumed to follow tissue 
engineering needs. All the information including starting and ending points of filament deposition on each 
slice, region based biomaterial and biomolecule concentration values as well as points where the region 
change is observed is printed in a G-code file to control 3D motion and the pressure levels for each 
biomaterial chamber. The code is then imported into the control unit to fabricate porous heterogeneous 
medical devices, in which overall composition changes along functionally gradient direction.   
2.6 Release Kinetics through Sodium Alginate Filaments  
While hybrid alginate devices have functionally graded regions with different biomaterial concentration, 
media penetration and hence biological modifier transport through the biomaterial mesh structure shows 
variability over the geometry. This necessitates determination of diffusion characteristics for each region. 
Data for solute diffusion in pure water aqD  
is extensively available in the literature [38]. The effective 
diffusion constant effD  for polymeric device can be then determined using the following relation [39]:    
2
3
1
1
)(
)(
Q
Q
DD aqeff


  (4) 
Q  in Equation (4) stands for the volume fraction of alginate in swollen state and can be found using 
the following relation discussed in [40]: 
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Where polymerp  
and solventp
 
are the densities of polymer and solvent, and aM  and bM  are the weight 
of the polymer after and before swelling, respectively. Although experimental swelling study has been 
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conducted for cylindrical alginate slabs where height (L) and diameter (d) are equal [41], a correction 
procedure is presented in Appendix A to determine the volume fraction of the alginate for cylindrical 
filaments (L>>d), while the device is constructed from laydown pattern of cylindrical alginate filaments.  
Penetration of media through alginate network is mediated by diffusion process. Diffusion of media 
through a cylindrical polymeric domain is modeled using Fick’s second law as in Equation (6), where D  
is the diffusion coefficient, C  is the media concentration at time t  and qr,  and z  denote radial, angular 
and axial directions, respectively.  
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(6) 
For cylindrical geometries with aspect ratios )( dL  , it has been shown that edge effects could be 
negligible [42]. Moreover, there is no concentration gradient of any of the three components with respect 
to q . By ignoring diffusion through angular and axial directions, Equation (6) can be simplified into 
Equation (7): 
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The solution of Equation (7) can be derived as in Equation (8) and experimentally validated in [39]: 
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 Where h  denotes the half length of the filament and r is the radius of the filament. a and b can be 
obtained by solving Equations (9)-(10). In Equation (8), m and n are integers and a stands for the root of a 
zero-order Bessel function
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Following approximation can be proposed for roots of a zero-order Bessel function when 10m :   
10      : 1   mmmm   
(11) 
Thus, Equations (8)-(11) can be used to determine the time based released kinetics through alginate 
filaments. Next section presents results and discussions. 
3 RESULTS AND DISCUSSIONS 
For implementation purposes, a digital image of a full thickness chronic wound [43] is used (Figure 2(a)). 
The digital image is processed in ImageJ software to extract 3D model of the wound bed surface as shown 
in Figure 2(b). Then, pixel points of the wound bed are transformed into 3D point cloud in CAD. Next, 
noise is eliminated and a 3
rd
 degree NURBS B-spline surface is fitted in Rhinoceros 4.0. Generated 3D B-
spline surface is presented in Figure 2(c).  
 
Figure 2: (a) A chronic wound image [43] from the literature is processed (b) using ImageJ software and 
(c) 3D NURBS surface is obtained in Rhinoceros. 
Based on linear wound healing fashion as discussed in the introduction section, 3D lofting is used to 
generate lofted surfaces as equal parameter distances between the wound surface and final healing point. 
Interpolation is performed between wound bed surface and final healing point as presented in Figure 3(a) 
and lofted surfaces  
Kkk
vuS
,...,1
),(

S  are obtained at equal parametric distances from the wound bed 
surface. Layer-by-layer manufacturing methodology is used to build 3D model in CAD (See Figure 3(c)). 
Functionally graded regions are then generated using lofted surfaces as boundaries using our earlier work 
a b c
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[30]. Figure 3(d) illustrates a 3D porous hybrid wound device highlighting functionally graded regions, 
where the wound device is portioned into 4 regions: Regions 1-4.   
 
Figure 3: (a) Linear wound healing fashion from wound bed surface to final healing point, (b) generation 
of lofted surface, and (c) a 3D hybrid wound device with functionally graded regions.   
 
In the next step, biomaterial and modifier concentration is determined according to tissue engineering 
requirements. There are several criteria to determine the loading concentrations such as viability condition 
of cells at different biomaterial concentrations, natural wound healing process, optimum biological 
modifier amount etc. Based on these requirements, loading of biomaterials and modifiers can be 
determined and release kinetics can be arranged accordingly.  
Figure 4 shows concentration level of sodium alginate and biomolecules in Regions 1-4 on the wound 
device illustrated in Figure 3(d). Requirements presented in Figure 4 are assumed to be tissue engineering 
needs. In general, alginate concentration over 5% is not suitable for cell viability and concentration under 
1% does not provide good mechanical integrity [41]. Thus, alginate concentration is preferred to be in the 
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range of 3% to 5%. Moreover, modifier concentration under 1% is in biologically relevant range [44]. 
Then, the concentration information is inputted into the fabrication system. A double layer of CAD model 
is printed through the deposition system with blending of two different alginate and modifier 
concentrations. Yellow and red inks in RGB are used for each alginate solutions to represent regional 
differentiation for visualization purposes. Only top layer is printed due to diffusive characteristics of color 
inks. The reader is referred to our earlier works for complex 3D fabrication on tissue replacement 
structures [45].  
 
Figure 4: Concentration of sodium alginate and biomolecules   
 
Based on requirements in Figure 4, a sample structure is printed in which the alginate concentration 
increases through the innermost region (Region 4). Figure 5 shows a sample fabricated wound dressing 
with 4 regions, in which regions are occupied by different alginate and modifier concentration based on 
the profile presented in Figure 4. 
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Figure 5: (a) Designed model in CAD and (b) fabricated wound device using multi-chamber single nozzle 
deposition system through 250µm nozzle tip.  
A random region from printed sample is analyzed and a dark field image is taken by a 5.0x1.0x1.0 
optic lenses. Loaded modifiers are highlighted in Figure 6. Different regions encapsulate different 
concentration of modifiers (UNIF (3-15 µm) in diameter). Using the experimental studies regarding the 
swelling characteristics of cylindrical alginate slabs at different concentration values from the literature 
[41] and applying the correction procedure to scale the swelling characteristics to a cylindrical filament 
given in Appendix A, swelling properties of alginate for various concentration ranges is obtained as in 
Table 1. As depicted in Table 1, volume fraction and density of alginate increases in the swollen state as 
alginate concentration increases. This can be explained by diminishing average mesh network opening 
size of alginate.  
 
Figure 6: Dark field image of encapsulated modifiers (beads) with a uniform size distribution of 3-15 µm 
using 5.0x1.0x1.0 optic lenses.   
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Table 1: Characterization of diffusion coefficient at different alginate concentrations 
Alginate  
Concentration (%) 
Ma/Mb 
 (Slab) 
Ma/Mb 
(filament) 
ppolymer  
(g/mL) 
psolvent 
(g/mL) 
Q 
 
1 73 16.576 1.01 1 0.060 
1.5 56 13.750 1.015 1 0.072 
2 42 11.209 1.02 1 0.088 
3 30 8.795 1.03 1 0.111 
 
In this work, effect of alginate concentration change over the release kinetics is analytically 
determined using Equations (8)-(11). For sake of demonstration, release kinetics of insulin is analyzed 
while it’s treatment is critical in chronic diabetic wounds [46]. Using the polymer fraction Q and the 
diffusion constant of insulin in pure aqueous solution Daq=10
-12
 m
2
/s [47], effective diffusion constant at 
different alginate concentrations is obtained and demonstrated in Figure 7. As can be depicted from the 
figure, diffusion coefficient decreases as the alginate concentration increases. This can be explained by 
the difficulty of media penetration with decrease in average network mesh opening diameter due to 
increased alginate concentration.  
 
Figure 7: Diffusion coefficient of insulin through alginate network at different concentrations 
Release kinetics of insulin is analyzed analytically through 250µm alginate filament under various 
concentration values using the developed methodology in Section 2.6 (See Figure 8). As the concentration 
of alginate increases, release kinetics slows down. Release of loaded insulin initializes with burst release 
and more than half of the protein releases within the first 2 hours. All concentration levels follow similar 
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release fashion starting with a burst release and continuing with decreasing rate of release kinetics. 
Release of insulin through 1% alginate concentration begins with 57% burst release in 2 hours and 
finalizes around 18h. Release of insulin through 1.5% alginate concentration however starts with 55% 
burst release and is completed in 24h. Increasing alginate concentration to 2% reduces the burst release 
and reduces the burst release to 53% at time 2h, in which release of insulin stops at 28h. The slowest 
release kinetics is attained at 3% alginate concentration in which 50% burst release is observed in 2h and 
release of insulin finalizes at 32h, which is almost double of total release time of insulin in 1% alginate 
concentration. As a result, change in concentration affects the release kinetics. Increasing alginate 
concentration slows down the release fashion.  
 
Figure 8: Insulin release through 250μm diameter micro-filaments for 4 different alginate concentrations 
Based on Equation (8)-(11), increase in filament diameter also brings deceleration in release kinetics 
that can be explained by the increased diffusion distance of biomolecules through the filament. Figure 9 
shows release kinetics profile for 250μm, 375μm and 500μm diameter micro-filaments at 2.5% alginate 
concentration. Increasing the filament diameter alleviates burst release and slows down the overall release 
fashion.   
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Figure 9: Insulin release through 250μm, 375μm and 500μm diameter micro-filaments for 2.5% alginate 
concentration. 
In this paper, concentration of alginate increases through the innermost region so that release of 
loaded modifiers decelerates through innermost region that can enable synchronization of wound healing 
with the release kinetics. In order to lessen the effect of burst release and adjust the release time in a way 
that it can be synchronized with the healing wound, drugs can be loaded inside microspheres rather than 
directly loaded inside the alginate filament. This also delays the total release time of loaded biomolecules. 
For instance, loading insulin inside polymeric microspheres delays the release time significantly. The 
other important factor during biological modifier release is hydrodynamic resistance. Polymer chains in 
alginates are considered as centers of hydrodynamic resistance. During protein diffusion throughout the 
alginates network, polymer chains slow down the protein transport especially in sites nearby cross-links. 
Transport behavior of proteins in alginates can thus be explained by reduction in alginate free volume, 
increased hydrodynamic drag and path length due to abstraction. Furthermore, proteins can cluster around 
polymer chains forming biomass. Due to the formation of biomass (also called biofouling), protein 
transport is limited further and reduced or incomplete release is observable. This can diminish 
bioavailability of the therapeutic agent and alters overall delivery profile as well [48]. Alginate polymer 
network, crosslinking chemistry, polymer size, protein type and size, encapsulating material, its thickness 
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and size, and surfactant type all play role in release kinetics of loaded proteins through alginate network 
[49-55].     
4 CONCLUSION 
In this paper, we propose a new hybrid wound device to control release kinetics spatiotemporally to 
enhance wound healing process. Spatial and temporal control in this work enables synchronization of 
wound healing with the release kinetics to advance cell proliferation and tissue healing. Spatiotemporal 
control of release kinetics is achieved by controlling the distribution of base biomaterial and loaded 
biological modifiers. The proposed release model reveals different release characteristics along 
functionally gradient variation direction. 
Transition from incorporation of a single modifier to multiple modifiers for wound care applications 
might be an engineering challenge and promising approach for improved and efficient tissue regeneration. 
As a future direction, wound devices needs to be designed and fabricated in a way that multiple proteins 
or growth factors should be impregnated and released in a specific spatial and temporal orientation to 
mimic the natural wound healing process. The authors are aiming at incorporating multiple proteins using 
the same bioprinting system to guide multiple clues in cell proliferation.        
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APPENDIX A 
Experimental study conducted in [41] reveals the swelling properties of cylindrical sodium alginate slabs 
with a size of 6mm in radius and 6mm in height; however, this data cannot be applied directly while 
deposited filaments with 250µm in diameter follows a different swelling mechanism. While length of 
deposited filaments is significantly large compared to the radius, axial expansion can be ignored. Swelling 
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study of cylindrical hydrogel slabs in [56] showed that radial and axial expansions are closed to each 
other. Thus corrected values of the swelling ratio can be obtained through the following scheme. Volume 
of the polymer or dried alginate Vp can be represented as in the following formula:         
3R
M
V
polymer
polymer
polymer 

  (A.1) 
Here Mpolymer and ρpolymer are the weight and density of the polymer, respectively. R is the filament radius 
which is equal to the height value. Expansion in radial and axial directions (ΔR) is same and weight of 
solvent in the swollen state can be calculated as in Equation (A.2), where Msolvent, ρsolvent and Vsolvent are the 
weight, the volume and the density of the solvent, respectively.         
    333 RRRVRR
M
V polymer
solvent
solvent
solvent 

  (A.2) 
Swelling of a micro-filament however does not account for the expansion in axial direction while axial 
diffusion can be ignored with the filament length which is more than 10 fold greater than it’s diameter 
[42]. Thus, corrected volume (
*
solventV ) and weight of the solvent (
*
solventM ) without axial expansion can be 
represented as:   
  22
*
* RRRR
M
V
solvent
solvent
solvent 

  (A.3) 
By rearranging Equations (A.1)-(A-3), corrected mass can be derived as in Equation (A.4), where 
b
a
M
M
is 
the swelling ratio obtained from the experimental study in [41]:   
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 (A.4) 
Corrected swelling ratio thus can be used to calculate the polymer fraction ratio in Equation (5) to find the 
effective diffusion constant at different alginate concentrations.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
20 
 
REFERENCES 
[1] R. Lanza, R. Langer, and J. Vacanti, Principles of Tissue Engineering. 3 ed2007: Elsevier. 
[2] C. Pereira, W. Gold, and D. Herndon, Review Paper: Burn Coverage Technologies: Current 
Concepts and Future Directions,  Journal of Biomaterials Applications  22 (2007) 101-121. 
[3] R. T. Tranquillo and J. D. Murray, Mechanistic Model of Wound Contraction,  Journal of 
Surgical Research  55 (1993) 233-247. 
[4] M. Cardinal, D. E. Eisenbud, and D. G. Amstrong, Wound shape geometry measurement predict 
eventual wound healing, in 18th Annual Meeting of Wound Healing Society2008: San Diego, 
CA. 
[5] A. E. Savakis and S. A. Maggelakis, Models of Shrinking Clusters with Applications to 
Epidermal Wound Healing,  Mathl. Comput. Modelin  25 (1997) 1-6. 
[6] G. J. Pettet, et al., A Model of Wound Healing Angiogenesis in Soft Tissue,  Mathematical 
Biosciences  136 (1995) 35-63. 
[7] A. Manios, et al., Computer assisted evaluation of wound healing in chronic ulcers,  Computers in 
Biology and Medicine  33 (2003) 311-317. 
[8] H. Sheardown and Y.-L. Cheng, Mechanism of Corneal Epithelial Wound Healing,  Chemical 
Engineering Science  51(19) (1995) 4517-4529. 
[9] F. W. H. Kloppenberg, G. I. J. M. Beerthuizen, and H. J. t. Duis, Perfusion of burn wounds 
assessed by Laser Doppler Imaging is related to burn depth and healing time,  Burns  27 (2001) 
359-363. 
[10] T. H. Helbich, et al., Noninvasive Assessment of Wound-healing Angiogenesis with Contrast-
enhanced MRI1,  Acad Radiol 9(suppl 1) (2002) S145-S147. 
[11] P. A. Yushkevich, et al., User-guided 3D active contour segmentation of anatomical structures: 
Significantly improved efficiency and reliability,  NeuroImage  31 (2006) 1116-1128. 
[12] M. Herbin, et al., Assessment of healing kinetics through true color image processing,  IEEE 
Trans Med Imaging 12(1) (1993) 39-43. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
21 
 
[13] F. X. Bon, et al., Quantitative and kinetic evolution of wound healing through image analysis.,  
IEEE Trans Med Imaging  19(7) (2000) 767-772. 
[14] G. L. Hansen, et al., Wound status evaluation using color image processing,  IEEE Trans Med 
Imaging  16 (1997) 78-86. 
[15] J. Liu, et al. Acomparative study of textures measures for human skin treatment. in Proceedings 
of International Conference on Information, Communication Signal Processing ICICS. 1997. 
Beijing, China. 
[16] C. Ribeiro, C. Barrias, and M. Barbosa, Calcium phosphate-alginate microspheres as enzyme 
delivery matrices,  Biomaterials  25(18) (2004) 4363-4373. 
[17] M. Agren, Four alginate dressings in the treatment of partial thickness wounds: a comparative 
experimental study,  British Journal of Plastic Surgery  49 (1996) 129-134. 
[18] G. Winter, Formation of the scab and the rate of epithelialization of superficial wounds in the skin 
of the young domestic pig,  Nature 193 (1962) 293-294. 
[19] C. Knill, et al., Alginate fibres modified with unhydrolysed and hydrolysed chitosans for wound 
dressings,  Polymers  55 (2004) 65-76. 
[20] S. Blair, et al., Clinical trial of calcium alginate haemostatic swabs,  British Journal of Plastic 
Surgery  77 (1990) 568-570. 
[21] G. M. Manaker, Wound Dressing in the new Millennium,  Seminars in Cutaneous Medicine and 
Surgery  21(2) (2002) 171-175. 
[22] I. T. Ozbolat, et al., Feature Based Bio-Modeling of Micro-patterned Structures for Tissue 
Engineering,  Computer-Aided Design and Applications  6(5) (2009) 661-671. 
[23] Q. Sun, et al., Sustained Release of Multiple Growth Factors from Injectable Polymeric System as 
a Novel Therapeutic Approach Towards Angiogenesis,  Pharmaceutical Research  27(2) (2010) 
267-271. 
[24] S. D. Putney and P. A. Burke, Improve protein therapeutics with sustained release formulations,  
Nature Biotecnol.  16 (1998) 153-157. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
22 
 
[25] D. J. Geer, D. D. Swartz, and S. T. Andreadis, Biomimetic Delivery of Keratinocyte Growth 
Factor upon Cellular Demand for Accelerated Wound Healing in Vitro and in Vivo,  American 
Journal of Pathology  167(6) (2005) 1575-1588. 
[26] S. R. S. Peppe, et al., Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by 
promoting angiogenesis in CD1 diabetic mice,  Gene Ther.  9 (2002) 1271–1277. 
[27] D. MacKay and A. L. Miller, Nutritional Support for Wound Healing,  Alternative Medicine 
Review  8(4) (2003) 359-377. 
[28] K. A. Choate and P. A. Khavari, Direct cutaneous gene delivery in a human genetic disease,  
Hum. Gene. Ter. 8 (1997) 201-211. 
[29] W. R. Gombotz and D. K. Pettit, Biodegredable Polymer for Protein and Peptite Drug Delivery 
Bioconjugate Chemistry  6 (1995) 332-351. 
[30] I. T. Ozbolat and B. Koc, Modeling of Spatially Controlled Bio-molecules in Three-dimensional 
Porous Alginate Structures ASME transactions, Journal of Medical Devices  4(4) (2010) 
041003(1)-041003(11). 
[31] RobertMcNeel&Associates, Rhinoceros 4.0, 2007: Seattle. 
[32] I. T. Ozbolat and B. Koc, 3D Engineered Wound Scaffolds for Spatiotemporally Controlled 
Release Kinetics, in Industrial Engineering Research Conference2011: Reno, Neveda. 
[33] L. Piegl and W. Tiller, The NURBS Book. 2nd ed1997, New York: Springer. 
[34] S. Khalil and W. Sun, Biopolymer deposition for freeform fabrication of hydrogel tissue 
constructs,  Material Science and Engineering: C  27(3) (2007) 469-478. 
[35] E. Sachlos and J. T. Czernuszka, Making Tissue Engineering Scaffolds Work: Review on the 
application of solid freeform fabrication technology to the production of tissue engineering 
scaffolds,  European Cells and Materials  5 (2003) 29-40. 
[36] R. Chang, J. Nam, and W. Sun, Computer-Aided Design, Modeling, and Freeform Fabrication of 
3D Tissue Constructs for Drug Metabolism Studies,  Computer-Aided Design and Application  5 
(2008) 21-29. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
23 
 
[37] R. Chang, J. Nam, and W. Sun, Direct Cell Writing of 3D Micro-organ for In Vitro 
Pharmacokinetic Model,  Tissue Engineering  14(2) (2008) 157-169. 
[38] B. Amsden, Solute Diffusion within Hydrogels. Mechanisms and Models,  Macromolecules  
31(23) (1998) 8382-8395. 
[39] M. Grassi and G. Grassi, Mathematical Modeling and Controlled Drug Delivery: Matrix Systems,  
Controlled Drug Delivery 2 (2005) 97-116. 
[40] A. R. Kulkarni, K. S. Soppimath, and T. M. Aminabhavi, Controlled release of diclofenac sodium 
from sodium alginate beads crosslinked with glutaraldehyde,  Pharmaceutica Acta Helvetiae 74 
(1999) 29-36. 
[41] S. Khalil, Deposition and Structural Formation of 3D Alginate Tissue Scaffold, in Mechaical 
Engineering Department2005, Drexel University: PA. 
[42] A. D. Polyanin, Handbook of Linear Partial Differential Equations for Engineers and Scientists  
2001, Bovs Raton: Chapman&Hall/CRC. 
[43] B. Albouy, Y. Lucas, and S. Treuillet, 3d Modeling from uncalibrated color images for a 
complete wound assessment tool, in Proceedings of the 29th Annual International Conference of 
the IEEE EMBS Cité Internationale2007: Lyon, France  
[44] S. A. Burns, et al., Determining the protein drug release characteristics and cell adhesion to a 
PLLA or PLGA biodegradable polymer membrane,  Journal of Biomedical Materials Research 
Part A  94A(1) (2010) 27-37. 
[45] A. Khoda, I. Ozbolat, and B. Koc, Engineered Tissue Scaffolds with Variational Porous 
Architecture,  ASME Transcations, Journal of Biomechanical Engineering  133(1) (2011) 
011001(1)-011001(12). 
[46] C. R. Kahn, et al., Joslin's Diabetes Mellitus. 14th ed2004: Lippincott Williams & Wilkins. 
[47] M. R. Rasmussen, T. Snabe, and L. H. Pedersen, Numerical modelling of insulin and 
amyloglucosidase release from swelling Ca-alginate beads,  journal of Controlled Release  91(3) 
(2003) 395-405. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
24 
 
[48] C. Lin and A. Metters, Hydrogels in controlled release formulations: Network design and 
mathematical modeling,  Advanced Drug Delivery Reviews  58 (2006) 1379-1408. 
[49] A. S. Hickey and N. A. Peppas, Mesh size and diffusive characteristics of semicrystalline 
poly(vinyl alcohol) membranes prepared by freezing/thawing techniques,  Journal of Membrane 
Science  107(3) (1995) 229-237. 
[50] L. Branno-Peppas, Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC 
Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas,  Biomaterials  18(5) (1997) 
449-449. 
[51] P. L. Ritger and N. A. Peppas, A simple equation for description of solute release II. Fickian and 
anomalous release from swellable devices,  journal of Controlled Release  5(1) (1987) 37-42. 
[52] J. L. Stringer and N. A. Peppas, Diffusion of small molecular weight drugs in radiation-
crosslinked poly(ethylene oxide) hydrogels,  journal of Controlled Release  42(2) (1996) 195-202. 
[53] N. A. Peppas, Devices based on intelligent biopolymers for oral protein delivery,  International 
Journal of Pharmaceutics  277(1-2) (2004) 11-17. 
[54] N. A. Peppas and L. Brannon-Peppas, Drug Delivery Biomaterials, in Encyclopedia of Materials: 
Science and Technology, eds. Editors, pp. 2351-2355(Elsevier, Oxford,  2001). 
[55] C. L. Bell and N. A. Peppas, Water, solute and protein diffusion in physiologically responsive 
hydrogels of poly(methacrylic acid-g-ethylene glycol),  Biomaterials  17(12) (1996) 1203-1218. 
[56] S. W. Kim, Y. H. Bae, and T. Okano, Hyogels: Swelling, Drug Loading, and Release,   9(3) 
(1992) 283-2390. 
 
 
Table 1: Characterization of diffusion coefficient at different alginate concentrations 
Alginate  
Concentration (%) 
Ma/Mb 
 (Slab) 
Ma/Mb 
(filament) 
ppolymer  
(g/mL) 
psolvent 
(g/mL) 
Q 
 
1 73 16.576 1.01 1 0.060 
1.5 56 13.750 1.015 1 0.072 
2 42 11.209 1.02 1 0.088 
3 30 8.795 1.03 1 0.111 
 
Tables
  
Figure 1: Morphing process: (a) lofted surface generation and (b) construction of lofted volume. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures
 Figure 2: (a) A chronic wound image [43] from the literature is processed (b) using ImageJ software and 
(c) 3D NURBS surface is obtained in Rhinoceros. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a b c
 Figure 3: (a) Linear wound healing fashion from wound bed surface to final healing point, (b) generation 
of lofted surface, and (c) a 3D hybrid wound device with functionally graded regions. 
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Figure 4: Concentration of sodium alginate and biomolecules   
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 Figure 5: (a) Designed model in CAD and (b) fabricated wound device using multi-chamber single nozzle 
deposition system through 250µm nozzle tip.  
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 Figure 6: Dark field image of encapsulated modifiers (beads) with a uniform size distribution of 3-15 µm 
using 5.0x1.0x1.0 optic lenses.   
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 Figure 7: Diffusion coefficient of insulin through alginate network at different concentrations 
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Figure 8: Insulin release through 250μm diameter micro-filaments for 4 different alginate concentrations 
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 Figure 9: Insulin release through 250μm, 375μm and 500μm diameter micro-filaments for 2.5% alginate 
concentration. 
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